Recombinant Human IL-10 (carrier-free)

Pricing & Availability
Regulatory Status
Other Names
Interleukin-10, B-TCGF, CSIF, TGIF
Ave. Rating
Submit a Review
Product Citations
Human IL-10 inhibits the induction of INFγ in PHA activated human PBMC.
  • Human_Il-10_RECOM_CF_102717
    Human IL-10 inhibits the induction of INFγ in PHA activated human PBMC.
Cat # Size Price Quantity Check Availability Save
571002 10 µg 165€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
571004 25 µg 329€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
571006 100 µg 1032€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
571008 500 µg 2344€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

IL-10 was first described as a cytokine that is produced by T helper 2 (Th2)cell clones. It inhibits interferon (IFN)-γ synthesis in Th1 cell, and therefore it was initially called cytokine synthesis inhibiting factor(CSIF). Macrophages are the main source of IL-10 and its secretion can be stimulated by endotoxin (via Toll-like receptor 4, NF-κB dependent), tumor necrosis factor TNF-α (via TNF receptor p55, NF-κB-dependent), catecholamines, and IL-1. IL-10 controls inflammatory processes by suppressing the expression of proinflammatory cytokines, chemokines, adhesion molecules, as well as antigen-presenting and costimulatory molecules in monocytes/macrophages, neutrophils, and T cells. IL-10 inhibits the production of proinflammatory mediators by monocytes and macrophages such as endotoxin- and IFN-γ-induced release of IL-1α, IL-6, IL-8, G-CSF, GM-CSF, and TNF-α. In addition, it enhances the production of anti-inflammatory mediators such as IL-1RA and soluble TNFα receptors. IL-10 inhibits the capacity of monocytes and macrophages to present antigen to T cells. This is realized by down-regulation of constitutive and IFNγ-induced cell surface levels of MHC class II, of costimulatory molecules such as CD86 and of some adhesion molecules such as CD58.

Product Details
Technical Data Sheet (pdf)

Product Details

Human IL-10, amino acids Ser19-Asn178 (Accession # NM_000572), was expressed in E. coli.
Molecular Mass
The 160 amino acid recombinant protein has a predicted molecular mass of 18,647 Da. The DTT-reduced protein migrates at approximately 18kDa and the non-reduced protein migrates at approximately 15kDa by SDS-PAGE. The N-terminal amino acid is Serine.
Purity is >98%, as determined by Coomassie stained SDS-PAGE.
0.22 µm filtered protein solution is in 10mM NaH2PO4, 150mM NaCl, pH 7.2.
Endotoxin Level
Endotoxin level is < 0.1 EU/µg (< 0.01ng/µg) protein as determined by the LAL method.
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Human IL-10 inhibits the induction of INFγ in PHA activated human PBMC. The ED50 = 0.025 - 0.25 ng/ml.


Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at

Product Citations
  1. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  2. Hleihel R, et al. 2023. Blood Cancer J. 13:67. PubMed
  3. Labadie KP, et al. 2023. Cancer Gene Ther. . PubMed
  4. Geary B, et al. 2023. Front Immunol. 1290585:14. PubMed
  5. Durlanik S, et al. 2021. Sci Rep. 11:14849. PubMed
  6. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  7. Brasil da Costa FH, et al. 2020. PLoS One. 15:e0230354. PubMed
  8. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed

Antigen Details


IL-10 is produce by Th2 cells, macrophages, DCs, B cells, CD8+ T cells, regulatory T cells (Tregs), Th1 cells and Th17 cells. In addition, IL-10 is expressed by monocytes, B cells, eosinophils, and mast cells.

IL-10 is an immunoregulatory cytokine. Its main function is the limitation and termination of inflammatory responses and the regulation of differentiation and proliferation of several immune cells such as T cells, B cells, natural killer cells, antigen-presenting cells, mast cells, and granulocytes.
IL-10R is expressed in monocytes, NK, B and T cells. In addition, Langerhans cells, dermal dendritic cells, eosinophils, mast cells, and endothelial cells can respond to IL-10.
IL-10 binds to their receptors IL-10R1 and IL-10R2, and initiates a STAT3-dependent signaling cascade.
Biology Area
Cell Biology, Immunology
Molecular Family
Antigen References

1. Fiorentino DF, et al. J Exp Med 170:2081-2095 1989.
2. Ho AS, et al. P. Natl. Acad. Sci. USA 90:11267-11271 1993.
3. Hart PH, et al. J Immunol 157:3672-3680 1996.
4. Asadullah K, et al. Pharmacol Rev 55:241-269 2003.
5. Mosser DM and Zhang X Immunol Rev 226:205-218 2008.
6. Maynard CL and Weaver CT Immunol Rev 226:219-233 2008.

Gene ID
3586 View all products for this Gene ID
View information about IL-10 on

Related FAQs

Why choose BioLegend recombinant proteins?

     • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.

How does the activity of your recombinant proteins compare to competitors?

We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!

What is the specific activity or ED50 of my recombinant protein?

The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.

Have your recombinants been tested for stability?

Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.

Does specific activity of a recombinant protein vary between lots?

Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?

Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)

Go To Top Version: 4    Revision Date: 10/27/2017

For Research Use Only. Not for diagnostic or therapeutic use.


This product is supplied subject to the terms and conditions, including the limited license, located at ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.


BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.


8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587


Login / Register
Remember me
Forgot your password? Reset password?
Create an Account